Document:

Exhibit 10.4

 

LOCK-UP
and resale restriction AGREEMENT

 

This lock-up and resale
restriction agreement (the “Agreement”) is made and entered into the 17th day of May, 2017, by and among PhotoMedex,
a Nevada corporation (the “Company”), First Capital Real Estate Trust Incorporated (“First Capital”)
and the persons executing this Agreement (each a “Holder” and, collectively, the “Holders”).

 

RECITALS

 

A.           First
Capital, First Capital Real Estate Operating Partnership, L.P. (the “Contributor”), the Company, and FC Global
Realty Operating Partnership, LLC (the “Acquiror”) have entered into a Contribution Agreement dated March 31,
2017 (the “Contribution Agreement”), pursuant to which the Contributor has agreed to contribute to the Acquiror
its interests in and to certain entities and real properties in exchange for certain securities of the Company. Capitalized terms
used herein and not otherwise defined herein shall have the respective meanings set forth in the Contribution Agreement.

 

B.           Each
Holder (i) is either an existing stockholder of the Company or, (ii) as a result of one or more of the Closings of the Transactions
contemplated in the Contribution Agreement, has acquired securities of the Company.

 

C.           As
a condition precedent to the Closing, each Holder is required to enter into this Agreement with the Company and First Capital.

 

AGREEMENT

 

NOW THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree
as follows:

 

1.             Restrictions
on Transfer. No Holder shall, directly or indirectly, prior to the termination of this Agreement: (i) transfer,
assign, sell, lend, sell short, gift-over, pledge, encumber, hypothecate, exchange or otherwise dispose (whether by sale, liquidation,
dissolution, dividend or distribution), or offer or solicit to do any of the foregoing, of any or all of the equity securities
and/or any debt or similar securities that are convertible into equity securities of the Company held by him, her or it, including
any additional equity securities and/or any debt or similar securities that are convertible into equity securities of the Company
which Holder may subsequently acquire, including all additional equity securities which may be issued to Holder upon the exercise
of any options, warrants or other securities convertible into or exchangeable for securities of the Company (all such securities
of such Holder, “Subject Securities”) or any right or interest therein, or consent to any of the foregoing (any
such action, a “Transfer”), (ii) enter or offer to enter into any derivative arrangement with respect to, or
create or suffer to exist any liens or encumbrances with respect to, any or all of the Subject Securities or any right or interest
therein, in either case that would reasonably be expected to prevent or delay such Holder’s compliance with his, her or its
obligations hereunder; or (iii) enter of offer to enter into any contract, option or other agreement, arrangement or understanding
with respect to any Transfer.

 

[Signature
Page to Lock-Up and Resale Restriction Agreement]

 

     

     

    

 

2.             Stop
Transfer Orders. Each Holder hereby acknowledges and agrees that the Company shall be entitled, during the term
of this Agreement, to cause any transfer agent for the Subject Securities to decline to effect any Transfer and to note stop transfer
restrictions on the stock register and other records relating to Subject Securities, and each Holder agrees to execute and deliver
any further documents reasonably requested by the Company in furtherance of the same.

 

3.             Permitted
Transfers. Notwithstanding the foregoing, the restrictions set forth herein shall not apply to the following Transfers
of Subject Securities by a Holder:

 

a.           if
such Holder is an individual (A) for nominal consideration or as a gift to any member of such Holder’s “immediate family”
(defined for purposes of this Agreement as the spouse, parents, lineal descendants, the spouse of any lineal descendant, and brothers
and sisters) or a trust for the benefit of such Holder or any member of such Holder’s immediate family, or (B) upon the death
of such Holder pursuant to a will or other instrument taking effect upon the death of such Holder, or pursuant to the applicable
laws of descent and distribution to such Holder’s estate, heirs or distributees; and

 

b.           if
the Holder is a corporation, partnership, limited liability company or other entity, any Transfer to an Affiliate of the Holder
if such Transfer is not for value;

 

provided, however,
that in the case of any Transfer described in clauses (a) or (b) above, it shall be a condition to the Transfer that (x) the transferee
executes and delivers to the Company, not later than one business day prior to such Transfer, a written agreement that is reasonably
satisfactory in form and substance to the Company to be bound by all of the terms of this Agreement and the Contribution Agreement
(any references to immediate family in the agreement executed by such transferee shall expressly refer only to the immediate family
of the Holder and not to the immediate family of the transferee) and (y) if the Holder is required to file a report under Section
16(a) of the Securities Exchange Act of 1934, as amended, reporting a reduction in beneficial ownership of the Subject Securities
or any securities convertible into or exercisable or exchangeable for the Subject Securities, the Holder shall include a statement
in such report to the effect that, in the case of any Transfer pursuant to (i) above, such Transfer is being made as a gift or
by will or intestate succession or, in the case of any Transfer pursuant to (ii) above, such Transfer is being made to a shareholder,
partner or member of, or owner of a similar equity interest in, the Holder and is not a Transfer for value.

 

c.           For
purposes hereof, “Affiliate” shall mean, with respect to any entity, any other person or entity directly or
indirectly controlling, controlled by or under common control with such entity. For purposes hereof, “control”
(including the terms “controlled by” and “under common control with”), as used with respect to any entity
or person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies
of such entity or person, whether through the ownership of voting securities or otherwise.

 

4.             Transfers
in Violation Void. Any attempted sale, transfer or other disposition in violation of this Agreement shall be null
and void.

 

    	 	2	 

     

    

 

5.             Binding
Effect; Waiver. This Agreement shall be binding upon the Holder, its agents, heirs, successors, assigns
and beneficiaries. Any waiver by the Company of any of the terms and conditions of this Agreement in any instance must be in writing
and must be duly executed by the Company and the Holder and shall not be deemed or construed to be a waiver of such term or condition
for the future, or of any subsequent breach thereof.

 

6.             Termination.
This Agreement, and all rights and obligations of the parties hereunder, shall terminate on the first anniversary of the Approval
Date or sooner upon the consent of the Company and First Capital.

 

7.             Miscellaneous.
Facsimile execution and delivery of this Agreement is legal, valid and binding execution and delivery for all purposes. This Agreement
shall not confer any rights or remedies upon any person other than the parties and their respective successors and permitted assigns.
This Agreement (including the documents referred to herein) constitutes the entire agreement among the Parties and supersedes any
prior understandings, agreements, or representations by or among the Parties, written or oral, to the extent they related in any
way to the subject matter hereof. This Agreement may be executed in one or more counterparts, each of which shall be deemed an
original but all of which together will constitute one and the same instrument. The Section headings contained in this Agreement
are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement. This Agreement
shall be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflicts
of laws. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not
affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending
term or provision in any other situation or in any other jurisdiction. Each of the parties will bear his or its own costs and expenses
(including legal fees and expenses) incurred in connection with this Agreement and the transactions contemplated hereby. Each arty
acknowledges and agrees that the other party would be damaged irreparably in the event any of the provisions of this Agreement
are not performed in accordance with their specific terms or otherwise are breached. Accordingly, each party agrees that the other
party shall be entitled to an injunction or injunctions to prevent breaches of the provisions of this Agreement and to enforce
specifically this Agreement and the terms and provisions hereof in any action instituted in any court of the United States or any
state thereof having jurisdiction over the Parties and the matter, in addition to any other remedy to which they may be entitled,
at law or in equity.

 

[Signature page follows]

 

    	 	3	 

     

    

 

IN WITNESS WHEREOF,
the undersigned have duly executed and delivered this Agreement as of the day and year first above written.

 

	Photomedex, Inc.	 
	 	 
	By:	/s/ Dolev Rafaeli 	 
	Name:	Dolev Rafaeli	 
	Title:	Chief Executive Officer	 
	 	 
	First Capital Real Estate Trust Incorporated	 
	 	 
	By:	/s/ Suneet Singal	 
	Name:	Suneet Singal	 
	Title:	Chief Executive Officer	 

 

	HOLDERS:	 
	 	 
	/s/ Lewis C. Pell	 
	Lewis C. Pell	 
	 	 
	/s/ Yoav Ben-Dror	 
	Yoav Ben-Dror	 
	 	 
	/s/ Dolev Rafaeli	 
	Dolev Rafaeli	 
	 	 
	/s/ Dennis M. McGrath	 
	Dennis M. McGrath	 
	 	 
	/s/ Katsumi Oneda	 
	Katsumi Oneda	 
	 	 
	/s/ Stephen P. Connelly	 
	Stephen P. Connelly	 

 

[Signature
Page to Lock-Up and Resale Restriction Agreement]

 

     

     

    

 

	First Capital Real Estate Investments LLC	 
	 	 
	By:	/s/
Suneet Singal                                     	 
	Name:	Suneet Singal	 
	Title:	Chief Executive Officer	 
	 	 
	FC Borrower LLC	 
	 	 
	By:	/s/
Suneet Singal	 
	Name:	Suneet Singal	 
	Title 	Chief Executive Officer	 

 

[Signature
Page to Lock-Up and Resale Restriction Agreement]Exhibit 10.5

 

EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT (the “Agreement”)
is dated and entered into as of May 17, 2017 by and between PhotoMedex, Inc., a corporation organized under the laws of the State
of Nevada (the “Company”), and Suneet Singal (the “Executive”).

 

WHEREAS, the Company desires to employ
the Executive, and the Executive desires to be employed by the Company, in each case on the terms and conditions contained herein.

 

NOW, THEREFORE, in consideration
of the foregoing premises and mutual covenants and agreements herein, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

 

1.             Term
of Employment. Subject to the provisions of Section 5 of this Agreement, the Executive shall be employed by the Company for
a period commencing on the date hereof (the “Effective Date”) and ending on the third (3rd) anniversary of the Effective
Date (the “Term”). The Term shall be renewed automatically for additional one (1) year period(s) unless terminated
by either the Company or the Executive in writing by notice to Executive delivered no fewer than ninety (90) days prior to expiration
of the then-applicable Term.

 

2.             Position.

 

(a)           Duties.
The principal duty of the Executive shall be to serve in the position of Chief Executive Officer of the Company. In such capacity,
the Executive shall be responsible for the operation and management of the business of the Company, subject to the direction and
control of the Board of Directors of the Company (the “Board”). All references to the “Board” in
this Agreement shall include any committee of the Board (including the Compensation Committee of the Board) that has been or is
in the future delegated the power of the Board to oversee and manage the compensation of the Company’s officers and employees.

 

(b)           Devotion
of Time to Company’s Business. The Executive shall use his best efforts, skills and abilities to promote and protect
the interests of the Company and devote sufficient working time and energies to the business and affairs of the Company. The Company
acknowledges and agrees that the Executive has and will continue to have executive and management responsibilities to First Capital
Real Estate Trust Incorporated and its subsidiaries and affiliates (collectively, “First Capital”) and that
nothing in this Agreement shall be construed to restrict or otherwise affect the obligations of the Executive to First Capital.
Further, notwithstanding anything to the contrary contained herein, the Executive (i) may serve on the board(s) of additional companies
or organizations and receive compensation for such services rendered (ii) may engage in charitable, civic, fraternal, professional,
trade association or other activities on behalf of private companies and receive compensation for such services rendered, provided
that in each such case the activities engaged in by the Executive do not materially interfere with his obligations to the Company,
and do not compete with the Company.

 

(c)           Directors
and Officers Liability Insurance. During the Term and for a period of six years thereafter, the Company, or any successor to
the Company resulting from a change in control, shall maintain a directors and officers liability insurance policy (or policies)
in a minimum amount of $5,000,000 which shall provide comprehensive coverage to Executive.

 

    	 	1	 

     

    

 

(d)           Best
Efforts. The Executive shall use his best efforts to carry out and successfully complete the assignments, tasks and job activities
required, from time to time, to be performed to carry out Executive’s duties and responsibilities during the Term. The Executive’s
duties and assignments shall be undertaken at such location(s) as may be determined from time to time by the Company, but in no
event shall Executive be required to perform his duties on a regular basis at any location more than 25 miles from the location
where Executive regularly performs his duties for the Company immediately prior to the Effective Date.

 

(e)           Company
Rules, Policies and Regulations. The Executive shall, at all times, conduct himself in a professional manner and adhere to
the standards, ethical obligations, rules, policies, regulations and procedures of the Company which are presently in force or
which may be established from time to time by the Company. Executive shall take no intentional action that violates any law, rule
or regulation whatsoever while acting in his capacity as employee.

 

3.             Compensation
and Benefits.

 

(a)         Compensation
and Benefits. At or as soon as possible following the Effective Date, the Executive shall make
a proposal to the compensation committee of the board of directors of the Company regarding the Executive’s base salary (the
“Base Salary”), bonus compensation, equity compensation and any other items of compensation or remuneration.
 The Executive shall also deliver to the compensation committee a report from a reputable compensation consultant that supports
the Executive’s proposal for compensation in the proposed range.  Within 10 days following the receipt of such proposal
and report, the compensation committee in good faith shall set the compensation for the Executive and this Agreement shall be promptly
amended to reflect such compensation. Once the compensation committee has set the compensation for the Executive as aforesaid,
the Company shall promptly make a lump sum payment to the Executive for compensation at that set level (less applicable deductions)
for the period from the Effective Date to the last day of the Company’s payroll period immediately preceding the date the
compensation is set, and the Executive will be entitled to compensation at the set rate from the first date of the each subsequent
payroll period.

 

(b)         Withholding.
All salaries, bonuses and other benefits payable to the Executive shall be subject to payroll, withholding and other taxes or deductions
as may be required by law.

 

4.             Employee
Benefits; Business Expenses.

 

(a)          Employee
Benefits. During the Term, the Executive and his dependents shall be entitled to participate in the Company’s healthcare
plans, welfare benefit plans, life insurance plans or policies, fringe benefit plans and any qualified or non-qualified retirement
plans as in effect from time to time (collectively, the “Employee Benefits”), on the same basis as those benefits
are made available to the other senior executives of the Company, in accordance with the Company policy as in effect from time
to time and in accordance with the terms of the applicable plan documents (if any). If at any time the Company does provide a health
insurance plan for which the Executive is eligible, the Executive shall be entitled to reimbursement by the Company of the cost
of health insurance paid by the Executive for the Executive and his family. Any such reimbursement shall be paid to the Executive
not later than March 15 of the year following the calendar year in which the Executive paid such cost. To the extent that the Company
does not provide a health insurance plan for which the Executive is eligible, the Executive shall be entitled to reimbursement
by the Company of the cost of health insurance paid by the Executive for the Executive and his family, which reimbursement shall
be grossed-up to cover any taxes the Executive would be required to pay as the result of the Company reimbursing the Executive
for the cost of the Executive’s health plan.

 

    	 	2	 

     

    

 

(b)          Perquisites.
During the Term, the Executive shall be entitled to receive such perquisites as are or have previously been made available to other
senior executives of the Company in accordance with Company policies as in effect from time to time.

 

(c)          Expenses.
The Executive shall be entitled to reimbursement for reasonable and necessary business expenses incurred by him in the performance
of his duties and responsibilities hereunder, such expenses to be documented and reimbursed in accordance with the Company’s
reimbursement and expenses policies as in effect from time to time.

 

(d)          Vacation.
The Executive shall be entitled to four (4) weeks paid vacation per annum; provided, that the Executive shall be paid annually
in cash for vacation days not taken by him; provided that no more than four (4) weeks of vacation may be accrued each year for
purposes of such cash payments; and provided further that any such payment shall be paid to the Executive not later than March
15 of the year following the calendar year in which the unused vacation days accrued.

 

5.             Termination.

 

(a)           Definitions.
For purposes of this Agreement:

 

(i)            “Cause”
shall mean (A) the Executive’s gross negligence and/or willful misconduct (as such terms are generally understood and applied
to the performance of an executive) in the performance of his material duties with respect to the Company as determined, in each
case, by a court of competent jurisdiction not subject to further appeal or a final arbitration award, as provided hereunder, (B)
the conviction by the Executive of a crime constituting a felony or (C) the Executive shall have committed any material act of
malfeasance, disloyalty, dishonesty or breach of fiduciary duty against the Company, for which the Executive shall have a ten (10)
day cure period following notice thereof from the Company (except for a conviction pursuant to subsection (B), for which there
shall be no cure period).

 

(ii)            “Change
of Control” means the occurrence of any one or more of the following events (it being agreed that, with respect to paragraphs
(A) and (C) of this definition below, a “Change of Control” shall not be deemed to have occurred if the applicable
third party acquiring party is an “affiliate” of the Company within the meaning of Rule 405 promulgated under the Securities
Act of 1933, as amended):

 

(A)          An
acquisition (whether directly from the Company or otherwise) of any voting securities of the Company (the “Voting Securities”)
by any “Person” (as the term person is used for purposes of Section 13(d) or 14(d) of the Securities and Exchange
Act of 1934, as amended (the “1934 Act”)), immediately after which such Person has “Beneficial Ownership”
(within the meaning of Rule 13d-3 promulgated under the 1934 Act) of forty percent (40%) or more of the combined voting power of
the Company’s then outstanding Voting Securities; or

 

(B)           The
individuals who, as of the consummation of any transaction or series of related transactions described in paragraphs (A) and (C)
of this definition, are members of the Board cease, by reason of transactions, to constitute at least fifty-one percent (51%) of
the members of the Board; or

 

(C)           The
consummation, in one or a series of related transactions, of:

 

    	 	3	 

     

    

 

(I)         A
merger, consolidation or reorganization involving the Company, where either or both of the events described in clauses (A) or (B)
above would be the result; or

 

(II)        The
sale or other disposition of all or substantially all of the assets of the Company to any Person (other than a transfer to a subsidiary
of the Company).

 

(iii)          “Date
of Termination” shall mean the date the Notice of Termination is given to the respective party; provided, however, that
with respect to a termination for Cause by the Company, the Date of Termination shall not occur prior to the expiration of any
applicable cure period.

 

(iv)          “Disability”
shall mean the Executive has become physically or mentally incapacitated and is therefore unable for a period of four (4) consecutive
months to perform any of the material elements of his duties hereunder. Any question as to whether the Executive has a Disability
as to which he (or his legal representative) and the Company cannot agree shall be determined in writing by a qualified independent
physician mutually acceptable to the Executive (or his legal representative) and the Company. If the Executive (or his legal representative)
and the Company cannot agree as to a qualified independent physician, each shall appoint such a physician and those two physicians
shall select a third who shall make such determination in writing. The determination of whether the Executive has a Disability,
as made in writing to the Company and the Executive by such physician(s), shall be final and conclusive for all purposes of this
Agreement.

 

(v)           “Good
Reason” shall mean (A) a breach by the Company of any of its material obligations or covenants or change to any of the
material terms set forth in this Agreement, (B) a material reduction of the duties, responsibilities or title of the Executive,
(C) the assignment to the Executive of any duties or responsibilities that are inconsistent, in any significant respect, with his
position, for which the Company shall have a ten (10) day cure period following notice thereof from Executive to the Company, (D)
an abandonment of, or fundamental change in, the primary business or primary products of the Company, (E) a Change of Control,
but only if the Executive’s termination occurs within twelve (12) months after the occurrence of such Change of Control.

 

(vi)         
“Notice of Termination” shall mean a notice which shall indicate the specific termination provision in this
Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination
of employment under the provision so indicated, and shall be communicated, in writing, to the other party hereto in accordance
with the provisions of Section 6(g) hereof.

 

(b)           By
the Company for Cause or by the Executive Without Good Reason.

 

(i)            The
Term and the Executive’s employment hereunder may be terminated by the Company for Cause, immediately upon the delivery of
a Notice of Termination by the Company to the Executive (except where the Executive is entitled to a cure period hereunder, in
which case such Date of Termination shall be upon the expiration of such cure period if such matter constituting Cause is not cured)
and shall terminate automatically upon the Executive’s resignation (other than for Good Reason or due to the Executive’s
death or Disability).

 

    	 	4	 

     

    

 

(ii)          If
the Executive’s employment is terminated by the Company for Cause, or if the Executive resigns other than for Good Reason,
the Executive shall be entitled to receive:

 

(A)          any
earned but unpaid Base Salary and/or accrued but unused vacation, all vested equity, and any earned but unpaid bonus awards through
the Date of Termination,

 

(B)          reimbursement
for any unreimbursed business expenses incurred by the Executive in accordance with the Company’s policy prior to the Date
of Termination (with such reimbursements to be paid promptly after the Executive provides the Company with the necessary documentation
of such expenses to the extent required by such policy but in no event later than the end of the second calendar month following
the year in which the Date of Termination occurred), and

 

(C)          such
Employee Benefits, if any, as to which he may be entitled upon termination of employment under the terms of the plan documents
and applicable law (including under the applicable provisions of Consolidated Omnibus Budget Reconciliation Act of 1985, as amended).

 

Following the Executive’s termination
of employment by the Company for Cause or if he resigns other than for Good Reason, except as set forth above or as required by
applicable law, the Executive shall have no further rights to any compensation or any other benefits or perquisites under this
Agreement and all unvested option or restricted stock grant awards shall immediately be cancelled without the need for any action
by the Company.

 

(c)           By
the Company Other Than for Cause or by the Executive for Good Reason.

 

(i)           The
Term and the Executive’s employment hereunder may be terminated by the Company other than for Cause, immediately upon the
delivery of a Notice of Termination by the Company to the Executive and shall terminate automatically and immediately upon the
Executive’s resignation for Good Reason at the end of any applicable cure period if the circumstances giving rise to Good
Reason are not cured.

 

(ii)           If
the Executive’s employment is terminated by the Company other than for Cause, or if the Executive resigns for Good Reason,
the Executive shall receive and the Company shall pay to Executive on the Date of Termination:

 

(A)          any
earned but unpaid Base Salary and/or accrued but unused vacation, all vested equity, and any earned but unpaid bonus awards through
the Date of Termination, plus an additional twelve (12) months of Annual Compensation (other than the case of a Change of Control,
in which case the payment shall be an additional eighteen (18) months of Annual Compensation), together in a lump sum payment;

 

(B)          acceleration
of any then-unvested stock options, restricted stock grants or other equity awards;

 

(C)          payment
or reimbursement, as applicable, of the full health insurance costs for the Executive and his family under a Company-provided group
health plan or otherwise for twenty-four (24) months following termination by the Company other than for Cause or resignation by
Executive for Good Reason, provided that any such payment or reimbursement which constitutes deferred compensation under Section
409A shall be made annually within thirty (30) days after the end of the calendar year in which the health insurance costs were
incurred;

 

    	 	5	 

     

    

 

(D)          in
the event any bonus or other form of additional compensation is paid to any other executive(s) of the Company for the fiscal year
during which Executive’s employment ceased pursuant to this Section 5(c), a cash amount equal to the largest bonus or other
form of additional compensation payment made by the Company to any other executive of the Company during such fiscal year, provided
that in the event such bonus or other form of compensation is not ascertainable on the Date of Termination, such payment shall
be made no later than March 15 of the year following the calendar year in which the Date of Termination occurred;

 

(E)          
reimbursement for any accrued but unused vacation days and/or unreimbursed business expenses incurred by the Executive in accordance
with the Company’s policy prior to the Date of Termination (with such reimbursements to be paid promptly after the Executive
provides the Company with the necessary documentation of such expenses to the extent required by such policy but in no event later
than the end of the second calendar month following the year in which the Date of Termination occurred); and

 

(F)           such
other Employee Benefits, if any, as to which he may be entitled upon termination of employment hereunder.

 

Following the Executive’s termination
of employment by the Company other than for Cause or if he resigns for Good Reason, except as set forth above or as required by
applicable law, the Executive shall have no further rights to any compensation or any other benefits under this Agreement. Notwithstanding
the foregoing, in order to be eligible for any of the severance payments and benefits under this Section 5(c), the Executive must
execute and deliver to the Company a general release in a form reasonably satisfactory to the Board. If the payments to be made
under this Section 5(c) are otherwise subject to Section 409A, they shall be made, or commence to be made, on the first pay period
following the date that is thirty (30) days after the Executive’s employment terminates. If the payments are not otherwise
subject to Section 409A, they shall be made, or commence to be made, on the first business day after the release becomes effective.
The initial payment shall include any unpaid amounts from the date the Executive’s employment terminated, subject to the
Executive’s executing and delivering the release on the terms as set forth above.

 

(d)           Death
or Disability. The Executive’s employment hereunder shall terminate upon the Executive’s death and may be terminated
by the Company, within ten (10) days after the delivery of a Notice of Termination by the Company to the Executive (or his legal
representative) in the event of the Executive’s Disability. Upon termination of the Executive’s employment hereunder
for either Disability or death, the Executive shall be entitled to receive the same payments and other items as set forth in clause
(ii) of Section 5(b) hereof, except that Executive (in case of Disability) or the estate (in the event of death) shall have the
right to exercise any unexercised and vested options for a period of 90 days, and, in addition, to receive payment for accrued
but unpaid vacation time, if any. Following the Executive’s termination of employment due to death or Disability, except
as set forth herein or as required by applicable law, the Executive (nor his estate) shall have no further rights to any compensation
or any other benefits under this Agreement.

 

    	 	6	 

     

    

 

(e)           Payment
of Amounts Owed upon Termination of Employment. Unless otherwise provided herein, any amounts payable to the Executive for
earned but unpaid Base Salary and cash, equity or other bonus awards through the Date of Termination shall be paid within ten (10)
business days after the Date of Termination.

 

6.             Miscellaneous.

 

(a)           Governing
Law. This Agreement shall be construed and governed under and by the laws of the State of New York, without regard to the conflicts
of laws principles thereof.

 

(b)           Arbitration
of Claims. In the event of any dispute, claim, question or disagreement arising from or relating to this Agreement or the breach
thereof (and except for cases in which the Company is entitled to injunctive or other equitable relief as described in Section
9 hereof), the Company and Executive agree to settle the dispute, claim, question or disagreement by arbitration before a single
arbitrator in the City of New York, New York, selected by, and such arbitration to be administered by, the American Arbitration
Association (“AAA”) in accordance with its Commercial Arbitration Rules, and judgment on the award rendered
by the arbitrator may be entered in any court having jurisdiction thereof. Each of the Company and Executive hereby agrees and
acknowledges that all disputes between or among them are subject to the alternative dispute resolution procedures of this Section
6(b). Each of the Company and Executive agrees that any aspect of alternative dispute resolution not specifically covered in this
Agreement shall be covered, without limitation, by the applicable AAA rules and procedures. Each of the Company and Executive further
agree that any determination by the arbitrator regarding any dispute, claim, question or disagreement arising from or relating
to this Agreement shall be final and binding upon the parties hereto and shall not be subject to further appeal. Each of the Company
and Executive shall bear its own costs and expenses and an equal share of the arbitrator’s fees and administrative fees of
arbitration; provided, however, that upon receipt of the determination by the arbitrator the prevailing party shall have all reasonable
out-of-pocket fees and expenses reimbursed promptly (in all events within 10 calendar days following delivery to both parties of
the arbitrator’s decision) by the non-prevailing party in any such dispute.

 

(c)           Entire
Agreement; Amendments. This Agreement sets forth the entire understanding of the parties concerning the subject matter of this
Agreement and incorporates all prior negotiations and understandings. There are no covenants, promises, agreements, conditions
or understandings, either oral or written, between them relating to the subject matter of this Agreement other than those set forth
herein. The publication, amendment, supplementation or replacement of an employee handbook by the Company shall not be deemed to
alter, amend or modify the terms and conditions of this Agreement. No alteration, amendment, change or addition to this Agreement
shall be binding upon any party unless in writing and signed by the party to be charged. No purported waiver by any party of any
default by another party of any term or provision contained herein shall be deemed to be a waiver of such term or provision unless
the waiver is in writing and signed by the waiving party. No such waiver shall in any event be deemed a waiver of any subsequent
default under the same or any other term or provision contained herein. This Agreement may not be altered, modified, or amended
except by written instrument signed by the parties hereto.

 

(d)           No
Waiver. No waiver of any of the provisions of this Agreement, whether by conduct or otherwise, in any one or more instances,
shall be deemed or be construed as a further, continuing or subsequent waiver of any such provision or as a waiver of any other
provision of this Agreement. No failure to exercise and no delay in exercising any right, remedy or power hereunder will preclude
any other or further exercise of any other right, remedy or power provided herein or by law or in equity.

 

    	 	7	 

     

    

 

(e)           Severability.
If any term or provisions of this Agreement, or the application thereof to any person or circumstance, shall be invalid or unenforceable,
the remainder of this Agreement, or the application of such term or provision to persons or circumstances, other than those as
to which it is held invalid, shall both be unaffected thereby and each term or provision of this Agreement shall be valid and be
enforced to the fullest extent permitted by law.

 

(f)            Assignment.
This Agreement, and the Executive’s rights and duties hereunder, shall not be assignable or delegable by the Executive; provided,
however, that if the Executive shall die, all amounts then payable to the Executive hereunder shall be paid in accordance with
the terms of this Agreement to the Executive’s devisee, legatee or other designee or, if there be no such devisee, legatee
or designee, to his estate. Upon such assignment, the rights and obligations of the Company hereunder shall become the rights and
obligations of such affiliate or successor person or entity.

 

(g)           Notices.
For the purpose of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall
be deemed to have been duly given when delivered by hand or internationally recognized courier service addressed to the respective
addresses set forth below in this Agreement, or via facsimile or email transmission to the number or email address set forth below,
or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice
of change of address shall be effective only upon receipt.

 

If to the Company:

 

Board of Directors

PhotoMedex, Inc.

2300 Computer Drive, Building G

Willow Grove, PA 19090

Attention: Dr. Dolev Rafaeli

 

If to the Executive:

 

Suneet Singal

_______________

_______________

 

(h)          Prior
Agreements. This Agreement supersedes all prior agreements and understandings (including verbal agreements) between the Executive
and the Company regarding the terms and conditions of the Executive’s employment with the Company.

 

(i)            Cooperation.
The Executive shall provide his reasonable cooperation in connection with any action or proceeding (or any appeal from any action
or proceeding) which relates to events occurring during the Executive’s employment hereunder, but only to the extent the
Company requests such cooperation with reasonable advance notice to the Executive and in respect of such periods of time as shall
not unreasonably interfere with the Executive’s ability to perform his duties with any subsequent employer; provided, however,
the Company shall pay any reasonable travel, lodging and related expenses that the Executive may incur in connection with providing
all such cooperation, to the extent approved by the Company prior to incurring such expenses.

 

(j)            Execution
and Counterparts. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by
facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and
binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if
such facsimile or “.pdf” signature page were an original thereof.

 

    	 	8	 

     

    

 

(k)           Section
409A.

 

(i)            The
parties intend that the payments and benefits provided for in this Agreement either be exempt from Section 409A, or be provided
in a manner that complies with Section 409A and any ambiguity herein shall be interpreted so as to be consistent with the intent
of this paragraph. In no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed
on the Executive by Section 409A or damages for failing to comply with Section 409A. Notwithstanding anything contained herein
to the contrary, all payments and benefits which are payable upon a termination of employment hereunder shall be paid or provided
only upon those terminations of employment that constitute a “separation from service” from the Company within the
meaning of Section 409A (determined after applying the presumptions set forth in Treas. Reg. Section 1.409A-1(h)(1)). Further,
if the Executive is a “specified employee” as such term is defined under Section 409A at the time of a termination
of employment and the deferral of the commencement of any payments or benefits otherwise payable hereunder as a result of such
termination of employment is necessary in order to prevent any accelerated recognition of income or additional tax under Section
409A, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction
in payments or benefits ultimately paid or provided to the Executive) until the date that is at least six (6) months following
the Executive’s termination of employment with the Company (or the earliest date permitted under Section 409A, e.g., immediately
upon the Executive’s death), whereupon the Company will promptly pay the Executive a lump-sum amount equal to the cumulative
amounts that would have otherwise been previously paid to the Executive under this Agreement during the period in which such payments
or benefits were deferred. Thereafter, payments will resume in accordance with this Agreement.

 

(ii)           Notwithstanding
anything to the contrary in this Agreement, in-kind benefits and reimbursements provided hereunder during any calendar year shall
not affect in-kind benefits or reimbursements to be provided in any other calendar year, other than an arrangement providing for
the reimbursement of medical expenses referred to in Section 105(b) of the Code, and are not subject to liquidation or exchange
for another benefit. Notwithstanding anything to the contrary in this Agreement, reimbursement requests must be timely submitted
by the Executive and, if timely submitted, reimbursement payments shall be promptly made to the Executive following such submission,
but in no event later than December 31st of the calendar year following the calendar year in which the expense was incurred. In
no event shall the Executive be entitled to any reimbursement payments after December 31st of the calendar year following the calendar
year in which the expense was incurred. This paragraph shall only apply to in-kind benefits and reimbursements that would result
in taxable compensation income to the Executive.

 

(iii)         Additionally,
in the event that following the date hereof the Company or the Executive reasonably determines that any compensation or benefits
payable under this Agreement may be subject to Section 409A, the Company and the Executive shall work together to adopt such amendments
to this Agreement or adopt other policies or procedures (including amendments, policies and procedures with retroactive effect),
or take any other commercially reasonable actions necessary or appropriate to (x) exempt the compensation and benefits payable
under this Agreement from Section 409A and/or preserve the intended tax treatment of the compensation and benefits provided with
respect to this Agreement or (y) comply with the requirements of Section 409A.

 

[Signature Page Follows]

 

    	 	9	 

     

    

 

IN WITNESS WHEREOF, the parties hereto
have duly executed this Agreement as of the day and year first above written.

 

	 	PHOTOMEDEX, INC.
	 	 	 	 
	 	By: 	/s/ Dolev Rafaeli
	 	 	Name:	Dolev Rafaeli
	 	 	Title:	Chief Executive Officer
	 	 	 	 
	 	EXECUTIVE:
	 	 	 	 
	 	/s/ Suneet Singal
	 	Suneet Singal

 

[Signature Page to Employment Agreement
– Suneet Singal]

 

    	 	10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}]]